← Browse by Condition
Medical Condition

chronic kidney disease and hypertension

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3

ClinicalMetric aggregates all active clinical trials for chronic kidney disease and hypertension from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT07222917 Phase 2
Recruiting

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Enrollment
218 pts
Location
United States, Argen...
Sponsor
AstraZeneca
View Trial →
NCT06742723 Phase 3
Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Enrollment
5,000 pts
Location
United States, Argen...
Sponsor
AstraZeneca
View Trial →